These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6766290)

  • 41. Impact of HR-1 on the therapy of end-stage uremia. How and where should uremia be treated.
    Friedman EA; Kountz SL
    N Engl J Med; 1973 Jun; 288(24):1286-8. PubMed ID: 4574109
    [No Abstract]   [Full Text] [Related]  

  • 42. An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard.
    Lee CP; Chertow GM; Zenios SA
    Value Health; 2009; 12(1):80-7. PubMed ID: 19911442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dialysis and transplant.
    Waterfall WK
    Br Med J; 1980 Sep; 281(6242):726-7. PubMed ID: 7000276
    [No Abstract]   [Full Text] [Related]  

  • 44. Cost-effectiveness of dialysis and kidney transplantation to treat end-stage renal disease in Ukraine.
    Hryshchuk SM; Parii VD
    Wiad Lek; 2024; 77(4):765-771. PubMed ID: 38865635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of end-stage renal failure in a defined geographic area.
    Bonney S; Finkelstein FO; Lytton B; Schiff M; Steele TE
    Arch Intern Med; 1978 Oct; 138(10):1510-3. PubMed ID: 361008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The costs of domiciliary maintenance haemodialysis. A comparison with alternative renal replacement regimens.
    Stewart JH; Topp ND; Martin S; Schawrowas E; Flaus Y; Sheil AG; Mahony JF
    Med J Aust; 1973 Jan; 1(4):156-9. PubMed ID: 4571627
    [No Abstract]   [Full Text] [Related]  

  • 47. Characteristics of Connecticut patients receiving services for end-stage uremia.
    Pearson DA; Stranova TJ; Thompson JD
    Public Health Rep; 1975; 90(5):440-8. PubMed ID: 809795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The cost of renal dialysis in a UK setting--a multicentre study.
    Baboolal K; McEwan P; Sondhi S; Spiewanowski P; Wechowski J; Wilson K
    Nephrol Dial Transplant; 2008 Jun; 23(6):1982-9. PubMed ID: 18174268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regionalized self-care hemodialysis. A solution to the increasing cost.
    Wauters JP; Hunziker A; Brunner HR
    JAMA; 1983 Jul; 250(1):59-62. PubMed ID: 6343655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of end-stage renal disease in Alabama.
    Melnick S
    Ala J Med Sci; 1983 Oct; 20(4):456-9. PubMed ID: 6359945
    [No Abstract]   [Full Text] [Related]  

  • 51. Cost analysis of alternative treatments in end-stage renal disease.
    Karlberg I
    Transplant Proc; 1992 Feb; 24(1):335. PubMed ID: 1539301
    [No Abstract]   [Full Text] [Related]  

  • 52. Self-care dialysis fits in with new economic challenges for providers.
    Usewicz MC
    Nephrol News Issues; 2011 Aug; 25(9):34-5. PubMed ID: 21905529
    [No Abstract]   [Full Text] [Related]  

  • 53. [Self dialysis: a new method of treatment for end-stage renal disease].
    Fournier G; Gaillard JL; Matha N; Man NK
    Nephrologie; 1984; 5(3):115-8. PubMed ID: 6493429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost comparison of kidney transplant versus dialysis in Brazil.
    Silva SB; Caulliraux HM; Araújo CA; Rocha E
    Cad Saude Publica; 2016 Jun; 32(6):. PubMed ID: 27383457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Economic and social aspects of treatment of chronic uremia].
    Lemmens P; Montag D; Toussaint C
    Brux Med; 1971 Nov; 51(11):751-5. PubMed ID: 4948826
    [No Abstract]   [Full Text] [Related]  

  • 56. [Dialysis versus renal transplantation; a comparative study on medical cost and quality of life in patients with chronic renal failure].
    Tajima A; Ueda D; Hirai M; Morinaga S; Sudoko H; Yamaguchi Y; Mitsuhashi T; Nakano M; Kanbayashi T; Ushiyama T
    Hinyokika Kiyo; 1987 Oct; 33(10):1536-41. PubMed ID: 3128069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F; Lau T; Luo N
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care.
    Manns B; Meltzer D; Taub K; Donaldson C
    Health Econ; 2003 Nov; 12(11):949-58. PubMed ID: 14601157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mortality of chronic hemodialysis and renal transplantation in pediatric end-stage renal disease.
    Avner ED; Harmon WE; Grupe WE; Ingelfinger JR; Eraklis AJ; Levey RH
    Pediatrics; 1981 Mar; 67(3):412-6. PubMed ID: 7017579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The economics of kidney transplantation versus hemodialysis.
    Loubeau PR; Loubeau JM; Jantzen R
    Prog Transplant; 2001 Dec; 11(4):291-7. PubMed ID: 11871278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.